{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:27:14Z","timestamp":1794378434361,"version":"4.9.0"},"reference-count":254,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neuropharm.2023.109756","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:22:14Z","timestamp":1696832534000},"page":"109756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence"],"prefix":"10.1016","volume":"241","author":[{"given":"Scott D.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-5781","authenticated-orcid":false,"given":"Detlev","family":"Boison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109756_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","article-title":"Purinergic signalling in the nervous system: an overview","volume":"32","author":"Abbracchio","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pnpbp.2004.11.008","article-title":"Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial","volume":"29","author":"Akhondzadeh","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2023.109756_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2005.463006.x","article-title":"Neurochemical underpinnings in bipolar disorder and epilepsy","volume":"46","author":"Amann","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0404.2000.101004217x.\/","article-title":"Homocysteine concentrations and methionine loading in patients on antiepileptic drugs","volume":"101","author":"Apeland","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2023.109756_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1176\/appi.psy.50.3.293","article-title":"Valacyclovir-induced psychosis and manic symptoms in an adolescent young woman with genital herpes simplex","volume":"50","author":"Aslam","year":"2009","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuropharm.2023.109756_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-1781(96)02909-5","article-title":"Sleep loss, a possible factor in augmenting manic episode","volume":"65","author":"Barbini","year":"1996","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/acps.13525","article-title":"The lithium paradox: declining prescription of the gold standard treatment for bipolar disorder","volume":"147","author":"Bartoli","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2023.109756_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10030160","article-title":"Purinergic signaling and related biomarkers in depression","volume":"10","author":"Bartoli","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/bjp.bp.115.180281","article-title":"Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials","volume":"210","author":"Bartoli","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.bcp.2007.12.007","article-title":"Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells","volume":"75","author":"Bastin-Coyette","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2023.109756_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1167.2005.463003.x","article-title":"Epidemiology of bipolar disorders","volume":"46","author":"Bauer","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102105","article-title":"ATP and adenosine-Two players in the control of seizures and epilepsy development","volume":"204","author":"Beamer","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib13","first-page":"1464","article-title":"The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men","volume":"76","author":"Beer","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2023.109756_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/hrt.37.6.668","article-title":"Advanced heart block aggravated by carbamazepine","volume":"37","author":"Beermann","year":"1975","journal-title":"Br. Heart J."},{"key":"10.1016\/j.neuropharm.2023.109756_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm1693","article-title":"Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor","volume":"14","author":"Bekar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2023.109756_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psyneuen.2015.10.014","article-title":"The HPA axis in bipolar disorder: systematic review and meta-analysis","volume":"63","author":"Belvederi Murri","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S1461145705006140","article-title":"Phenytoin: an anti-bipolar anticonvulsant?","volume":"9","author":"Bersudsky","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2023.109756_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1528-1167.2007.01068.x","article-title":"The relevance of kindling for human epilepsy","volume":"48","author":"Bertram","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/jnnp.43.12.1098","article-title":"A study of the incidence of epilepsy following ECT","volume":"43","author":"Blackwood","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pneurobio.2007.12.002","article-title":"The adenosine kinase hypothesis of epileptogenesis","volume":"84","author":"Boison","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib252","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eplepsyres.2009.03.019","article-title":"Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies","volume":"85","author":"Boison","year":"2009","journal-title":"Epilepsy Res"},{"issue":"Suppl. 5","key":"10.1016\/j.neuropharm.2023.109756_bib253","article-title":"Adenosine augmentation therapy for epilepsy","volume":"51","author":"Boison","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib22","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"Adenosine augmentation therapy","author":"Boison","year":"2012"},{"key":"10.1016\/j.neuropharm.2023.109756_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","article-title":"New insights into the mechanisms of the ketogenic diet","volume":"30","author":"Boison","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2015.04.031","article-title":"Comorbidities in Neurology: is adenosine the common link?","volume":"97","author":"Boison","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107741","article-title":"Epigenetics and epilepsy prevention: the therapeutic potential of adenosine and metabolic therapies","volume":"167","author":"Boison","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.neuropharm.2011.01.048","article-title":"Adenosine hypothesis of schizophrenia - opportunities for pharmacotherapy","volume":"62","author":"Boison","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib27","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.2174\/1570159X20666220411081728","article-title":"What is the role of lithium in epilepsy?","volume":"20","author":"Bojja","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib28","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1016\/S0021-9258(17)38001-8","article-title":"Effect of diet on adenylosuccinase activity in various organs of rat and chicken","volume":"253","author":"Brand","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib29","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1074\/jbc.M308778200","article-title":"Entla: a novel epileptic and ataxic Cacna2d2 mutant of the mouse","volume":"279","author":"Brill","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib30","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1345\/aph.1H222","article-title":"Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia","volume":"40","author":"Buie","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2023.109756_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109756_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib33","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pnpbp.2008.08.007","article-title":"Peripheral nucleotide hydrolysis in rats submitted to a model of electroconvulsive therapy","volume":"32","author":"Busnello","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110299","article-title":"Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K\/AKT\/HIF1-a pathway","volume":"145","author":"Campbell","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2023.109756_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neubiorev.2019.05.023","article-title":"Cortisol levels and seizures in adults with epilepsy: a systematic review","volume":"103","author":"Cano-Lopez","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2023.109756_bib36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1471-4159.1994.62031144.x","article-title":"Differential distribution of purine metabolizing enzymes between glia and neurons","volume":"62","author":"Ceballos","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajp.2018.04.030","article-title":"Serum uric acid levels in first episode mania, effect on clinical presentation and treatment response: data from a case control study","volume":"35","author":"Chatterjee","year":"2018","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.neuropharm.2023.109756_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2017.09.034","article-title":"Allopurinol augmentation in acute mania: a meta-analysis of placebo-controlled trials","volume":"226","author":"Chen","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fpsyt.2019.00767","article-title":"Patients with drug-naive bipolar disorder in remission after 8 Weeks of treatment had decreased serum uric acid concentrations","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.eururo.2015.03.031","article-title":"Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis","volume":"68","author":"Chen","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.38917","article-title":"Nocturnal risk of gout attacks","volume":"67","author":"Choi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105454","article-title":"Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus","volume":"184","author":"Choi","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neuropharm.2023.109756_bib44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1073\/pnas.0811685106","article-title":"G protein-activated inwardly rectifying potassium channels mediate depotentiation of long-term potentiation","volume":"106","author":"Chung","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2023.109756_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2009.07.012","article-title":"Increased risk of gout among patients with bipolar disorder: a nationwide population-based study","volume":"180","author":"Chung","year":"2010","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib46","first-page":"301","article-title":"Neurologic aspects of adenylosuccinate lyase deficiency","volume":"16","author":"Ciardo","year":"2001","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0736-5748(00)00084-8","article-title":"Involvement of astrocytes in purine-mediated reparative processes in the brain","volume":"19","author":"Ciccarelli","year":"2001","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib48","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.bmcl.2014.04.034","article-title":"Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase","volume":"24","author":"Converso","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2023.109756_bib49","first-page":"469","article-title":"Hypothalamic-pituitary-adrenal axis and bipolar disorder","volume":"28","author":"Daban","year":"2005","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.neuropharm.2023.109756_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1089871","article-title":"Purine signaling pathway dysfunction in autism spectrum disorders: evidence from multiple omics data","volume":"16","author":"Dai","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib51","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.2147\/NDT.S84852","article-title":"Managing drug-resistant epilepsy: challenges and solutions","volume":"12","author":"Dalic","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2023.109756_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1096-9861(19980831)398:3<333::AID-CNE3>3.0.CO;2-0","article-title":"Expression of purine metabolism-related enzymes by microglial cells in the developing rat brain","volume":"398","author":"Dalmau","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.951376","article-title":"The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients","volume":"13","author":"Danan","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12060712","article-title":"Uric acid and cortisol levels in plasma correlate with pre-competition anxiety in novice athletes of combat sports","volume":"12","author":"de Oliveira","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-3908(89)90095-6","article-title":"Antagonists of adenosine and alpha-2-adrenoceptors reverse the anticonvulsant effects of tizanidine in DBA\/2 mice","volume":"28","author":"De Sarro","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib56","doi-asserted-by":"crossref","first-page":"20812","DOI":"10.1074\/jbc.M211813200","article-title":"The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine","volume":"278","author":"Detich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.molmed.2018.07.005","article-title":"P2X7 receptor: a potential therapeutic target for depression?","volume":"24","author":"Deussing","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2023.109756_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yebeh.2016.05.024","article-title":"Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats","volume":"61","author":"Dhediya","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109756_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1046471","article-title":"Bipolar spectrum disorders in neurologic disorders","volume":"13","author":"Digiovanni","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib60","first-page":"834","article-title":"Lithium and brain adenyl cyclase","volume":"1","author":"Dousa","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2023.109756_bib61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-6147(86)90285-3","article-title":"Adenosine: the brain's natural anticonvulsant?","volume":"7","author":"Dragunow","year":"1986","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1528-1157.1985.tb05684.x","article-title":"Is adenosine an endogenous anticonvulsant?","volume":"26","author":"Dragunow","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib63","first-page":"575","article-title":"[Sensitivity of the clonidine and guanfacine tests (alpha-2-adrenergic agonists) as pharmacologic stimulants of growth hormone. Effects on plasma cortisol]","volume":"45","author":"Dura Trave","year":"1996","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.neuropharm.2023.109756_bib64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410320504","article-title":"Adenosine: a potential mediator of seizure arrest and postictal refractoriness","volume":"32","author":"During","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib65","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1044\/2019_AJA-19-0009","article-title":"Diurnal cortisol levels and subjective ratings of effort and fatigue in adult cochlear implant users: a pilot study","volume":"28","author":"Dwyer","year":"2019","journal-title":"Am. J. Audiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2008.12.056","article-title":"Sleep deprivation increases A(1) adenosine receptor density in the rat brain","volume":"1258","author":"Elmenhorst","year":"2009","journal-title":"Brain Res."},{"issue":"Suppl. 8","key":"10.1016\/j.neuropharm.2023.109756_bib67","first-page":"9","article-title":"Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders","volume":"64","author":"Evins","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib68","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3389\/fmicb.2019.01762","article-title":"Pseudomonas aeruginosa polynucleotide phosphorylase contributes to ciprofloxacin resistance by regulating PrtR","volume":"10","author":"Fan","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2007-1001816","article-title":"[Lithium prevention of depression 100 years ago--an ingenious misconception]","volume":"55","author":"Felber","year":"1987","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bdi.12990","article-title":"The impact of caffeine consumption on clinical symptoms in patients with bipolar disorder: a systematic review","volume":"23","author":"Frigerio","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib71","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF00179186","article-title":"Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors","volume":"90","author":"Fujiwara","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109756_bib72","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/adb.12316","article-title":"Pulling habits out of rats: adenosine 2A receptor antagonism in dorsomedial striatum rescues meth-amphetamine-induced deficits in goal-directed action","volume":"22","author":"Furlong","year":"2017","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib73","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.0013-9580.2005.59704.x","article-title":"Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment","volume":"46","author":"Galimberti","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib74","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.brs.2014.12.012","article-title":"Predictors of seizure threshold in right unilateral ultrabrief electroconvulsive therapy: role of concomitant medications and anaesthesia used","volume":"8","author":"Galvez","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2023.109756_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02219713","article-title":"Treatment of benzodiazepine withdrawal symptoms with carbamazepine","volume":"241","author":"Garcia-Borreguero","year":"1991","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113598","article-title":"Emerging role of purine metabolizing enzymes in brain function and tumors","volume":"19","author":"Garcia-Gil","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/809843","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","author":"Garcia","year":"2012","journal-title":"Epilepsy Res Treat 2012"},{"key":"10.1016\/j.neuropharm.2023.109756_bib78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4306\/pi.2013.10.3.218","article-title":"Bipolar spectrum: a review of the concept and a vision for the future","volume":"10","author":"Ghaemi","year":"2013","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.neuropharm.2023.109756_bib79","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/088307380001501203","article-title":"The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones","volume":"15","author":"Gilbert","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1060884","article-title":"Individualized medical treatment options in Cushing disease","volume":"13","author":"Gilis-Januszewska","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib81","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.brs.2022.05.020","article-title":"Deep brain stimulation of the anterior thalamus attenuates PTZ kindling with concomitant reduction of adenosine kinase expression in rats","volume":"15","author":"Gimenes","year":"2022","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2023.109756_bib82","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S1092852915000577","article-title":"Deep brain stimulation for bipolar disorder-review and outlook","volume":"22","author":"Gippert","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib83","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105363","article-title":"Of adenosine and the blues: the adenosinergic system in the pathophysiology and treatment of major depressive disorder","volume":"163","author":"Gomes","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40263-022-00934-0","article-title":"The purinergic system as a target for the development of treatments for bipolar disorder","volume":"36","author":"Goncalves","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2023.109756_bib86","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40259-015-0144-3","article-title":"Selective phosphodiesterase inhibitors for psoriasis: focus on apremilast","volume":"29","author":"Gooderham","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.neuropharm.2023.109756_bib87","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jnc.12366","article-title":"Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling","volume":"127","author":"Gottle","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib88","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","article-title":"Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy","volume":"44","author":"Gouder","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02916252","article-title":"Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study","volume":"247","author":"Greil","year":"1997","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib90","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.49.5.1389","article-title":"Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children","volume":"49","author":"Griesemer","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113562","article-title":"Lithium-induced neuroprotective activity in neuronal and microglial cells: a purinergic perspective","volume":"295","author":"Gubert","year":"2021","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib92","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","article-title":"Role of P2X7 receptor in an animal model of mania induced by D-amphetamine","volume":"53","author":"Gubert","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib93","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/NDT.S256699","article-title":"Clinical management of drug resistant epilepsy: a review on current strategies","volume":"17","author":"Guery","year":"2021","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2023.109756_bib94","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0594","article-title":"Astrocytic adenosine: from synapses to psychiatric disorders","volume":"369","author":"Hines","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib95","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1038\/tp.2012.136","article-title":"Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling","volume":"3","author":"Hines","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000559","article-title":"High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIalpha as a clock regulatory kinase","volume":"8","author":"Hirota","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BFb0033648","article-title":"Voltage-dependent calcium channels: from structure to function","volume":"139","author":"Hofmann","year":"1999","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jnc.12287","article-title":"The role of tetrahydrobiopterin and catecholamines in the developmental regulation of tyrosine hydroxylase level in the brain","volume":"126","author":"Homma","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib99","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2174\/156802611795347654","article-title":"The role of adenosine in the regulation of sleep","volume":"11","author":"Huang","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/1570159X13666150630171954","article-title":"Pharmacological approaches for treatment-resistant bipolar disorder","volume":"13","author":"Hui Poon","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-5618.2007.00430.x","article-title":"Disability and its treatment in bipolar disorder patients","volume":"9","author":"Huxley","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib102","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fnmol.2019.00331","article-title":"Pathological ATPergic signaling in major depression and bipolar disorder","volume":"12","author":"Illes","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib103","first-page":"435","article-title":"Lithium and psoriasis: what primary care and family physicians should know","volume":"10","author":"Jafferany","year":"2008","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(01)02189-9","article-title":"Changes in P2Y and P2X purinoceptors in reactive glia following axonal degeneration in the rat optic nerve","volume":"312","author":"James","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109756_bib105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12264-016-0094-x","article-title":"Potential mechanisms underlying the therapeutic effects of electroconvulsive therapy","volume":"33","author":"Jiang","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2023.109756_bib106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fneur.2020.00327","article-title":"Epilepsy and its interaction with sleep and circadian rhythm","volume":"11","author":"Jin","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib107","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2023.109756_bib108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10545-014-9755-y","article-title":"Adenylosuccinate lyase deficiency","volume":"38","author":"Jurecka","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuropharm.2023.109756_bib109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2010.06.024","article-title":"Postictal affective episodes","volume":"19","author":"Kanner","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109756_bib110","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0735-1097(92)90285-U","article-title":"Adenosine-induced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways","volume":"19","author":"Keim","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib111","first-page":"981","article-title":"Increased uric acid levels in bipolar disorder: is it trait or state?","volume":"27","author":"Kesebir","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.neuropharm.2023.109756_bib112","doi-asserted-by":"crossref","first-page":"F1139","DOI":"10.1152\/ajprenal.00718.2012","article-title":"Lithium: a versatile tool for understanding renal physiology","volume":"304","author":"Kishore","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib113","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/epi.13360","article-title":"Adenosine A1 receptor-mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices","volume":"57","author":"Klaft","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/epi.13965","article-title":"Commonalities in epileptogenic processes from different acute brain insults: do they translate?","volume":"59","author":"Klein","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yebeh.2015.07.003","article-title":"Epilepsy and bipolar disorder","volume":"52","author":"Knott","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109756_bib116","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/s41467-021-23301-x","article-title":"Reversible modulation of circadian time with chronophotopharmacology","volume":"12","author":"Kolarski","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109756_bib117","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.26208","article-title":"Sleep deprivation exacerbates seizures and diminishes GABAergic tonic inhibition","volume":"90","author":"Konduru","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib118","series-title":"Manic-depressive Insanity and Paranoia","author":"Kraepelin","year":"1921"},{"key":"10.1016\/j.neuropharm.2023.109756_bib119","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ajad.12210","article-title":"Caffeine-induced mania in a patient with caffeine use disorder: a case report","volume":"24","author":"Krankl","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2023.109756_bib120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0920-1211(87)90007-6","article-title":"Antiepileptic drugs reduce serum uric acid","volume":"1","author":"Krause","year":"1987","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib121","first-page":"206","article-title":"Integration of neuronal and glial signalling by pyramidal cells of the rat prefrontal cortex; control of cognitive functions and addictive behaviour by purinergic mechanisms","volume":"15","author":"Krugel","year":"2013","journal-title":"Neuropsychopharmacol Hung"},{"key":"10.1016\/j.neuropharm.2023.109756_bib122","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/WNF.0000000000000222","article-title":"Effect of excessive coffee consumption on the clinical course of a patient with bipolar disorder: a case report and literature review","volume":"40","author":"Kunitake","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2018.02.012","article-title":"Uric acid and allopurinol aggravate absence epileptic activity in Wistar Albino Glaxo Rijswijk rats","volume":"1686","author":"Lakatos","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.seizure.2012.07.010","article-title":"Refractory status epilepticus: electroconvulsive therapy as a possible therapeutic strategy","volume":"21","author":"Lambrecq","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109756_bib125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2017.05.029","article-title":"Antibiotics and mania: a systematic review","volume":"219","author":"Lambrichts","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib126","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0026-0495(83)90026-4","article-title":"Decreased secretion of cortisol and ACTH after oral clonidine administration in normal adults","volume":"32","author":"Lanes","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2023.109756_bib127","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/164_2017_36","article-title":"Adenosine and sleep","volume":"253","author":"Lazarus","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.90","article-title":"Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene","volume":"5","author":"Lee","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib254","first-page":"571","article-title":"Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice","volume":"118","author":"Li","year":"2008","journal-title":"J Clin Inv"},{"key":"10.1016\/j.neuropharm.2023.109756_bib129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3371\/CSRP.LION.020113","article-title":"Rapid resolution of psychotic symptoms in a patient with schizophrenia using allopurinol as an adjuvant: a case report","volume":"7","author":"Linden","year":"2014","journal-title":"Clin. Schizophrenia Relat. Psychoses"},{"key":"10.1016\/j.neuropharm.2023.109756_bib130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bcp.2013.07.009","article-title":"Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole","volume":"86","author":"Liu","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib131","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuroscience.2015.08.041","article-title":"Animal models of bipolar mania: the past, present and future","volume":"321","author":"Logan","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109756_bib132","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","article-title":"S-Adenosylmethionine","volume":"32","author":"Lu","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib133","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97955-4","article-title":"Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study","volume":"11","author":"Lu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109756_bib134","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yebeh.2006.06.013","article-title":"Electroconvulsive therapy in patients with epilepsy","volume":"9","author":"Lunde","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109756_bib135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2023.109756_bib136","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib137","doi-asserted-by":"crossref","first-page":"577","DOI":"10.12740\/PP\/97335","article-title":"Disturbances of purinergic system in affective disorders and schizophrenia","volume":"53","author":"Malewska-Kasprzak","year":"2019","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib138","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1535-7597.2004.04509.x","article-title":"Sleep deprivation and epilepsy","volume":"4","author":"Malow","year":"2004","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136116","article-title":"Mini review: recent advances on epigenetic effects of lithium","volume":"761","author":"Marie-Claire","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109756_bib140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tins.2008.02.009","article-title":"Are purines mediators of the anticonvulsant\/neuroprotective effects of ketogenic diets?","volume":"31","author":"Masino","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib141","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI57813","article-title":"A ketogenic diet suppresses seizures in mice through adenosine A1 receptors","volume":"121","author":"Masino","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109756_bib142","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.semcdb.2011.02.011","article-title":"Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders","volume":"22","author":"Matute","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib143","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00345-005-0015-5","article-title":"Phosphodiesterase inhibitors in female sexual dysfunction","volume":"23","author":"Mayer","year":"2005","journal-title":"World J. Urol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib144","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/10738584070130041101","article-title":"Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions","volume":"13","author":"Mazza","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2023.109756_bib145","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2023.109756_bib146","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2125.2005.02431.x","article-title":"Ziprasidone decreases cortisol excretion in healthy subjects","volume":"60","author":"Meier","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib147","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.schres.2012.07.029","article-title":"Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg\/day, but does not enhance efficacy of haloperidol, 2mg\/day: comparison with reference dose risperidone, 6mg\/day","volume":"141","author":"Meltzer","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib148","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.jmb.2020.01.003","article-title":"Pharmacological interventions to circadian clocks and their molecular bases","volume":"432","author":"Miller","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib149","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1471-4159.1984.tb06078.x","article-title":"Lesch-Nyhan syndrome, caffeine model: increase of purine and pyrimidine enzymes in rat brain","volume":"43","author":"Minana","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fncel.2014.00312","article-title":"Role of adenosine in the antiepileptic effects of deep brain stimulation","volume":"8","author":"Miranda","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib151","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/JCP.0000000000001360","article-title":"Long-term improvement of aggression in a patient with schizophrenia using allopurinol as an adjuvant: a case report","volume":"41","author":"Miyauchi","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib152","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(85)90346-2","article-title":"Possible mechanism of action of diazepam as an adenosine potentiator","volume":"113","author":"Moritoki","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib153","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3810\/pgm.2010.07.2171","article-title":"The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal","volume":"122","author":"Mula","year":"2010","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.neuropharm.2023.109756_bib154","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/ern.09.139","article-title":"Epilepsy and bipolar disorders","volume":"10","author":"Mula","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2023.109756_bib155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1756285609337340","article-title":"Depression in epilepsy: mechanisms and therapeutic approach","volume":"2","author":"Mula","year":"2009","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib156","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.psychres.2014.11.038","article-title":"Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium","volume":"225","author":"Muti","year":"2015","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib157","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/bdi.13283","article-title":"Brain stimulation treatment for bipolar disorder","volume":"25","author":"Mutz","year":"2023","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib158","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14756366.2022.2061965","article-title":"Interactions of 2,6-substituted purines with purine nucleoside phosphorylase from Helicobacter pylori in solution and in the crystal, and the effects of these compounds on cell cultures of this bacterium","volume":"37","author":"Narczyk","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib159","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jare.2014.12.005","article-title":"Brain stem adenosine receptors modulate centrally mediated hypotensive responses in conscious rats: a review","volume":"6","author":"Nassar","year":"2015","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","volume":"7","author":"Neal","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib161","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/j.1528-1167.2006.00893.x","article-title":"Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period","volume":"47","author":"Nishida","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib162","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF01968126","article-title":"Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside","volume":"9","author":"Nishida","year":"1979","journal-title":"Agents Actions"},{"key":"10.1016\/j.neuropharm.2023.109756_bib163","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroscience.2014.02.012","article-title":"Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation","volume":"266","author":"Noh","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109756_bib164","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41386-018-0028-6","article-title":"Cell-subtype-specific changes in adenosine pathways in schizophrenia","volume":"43","author":"O'Donovan","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/jacs.9b08698","article-title":"Metabolic-pathway-oriented screening targeting S-Adenosyl-l-methionine reveals the epigenetic remodeling activities of naturally occurring catechols","volume":"142","author":"Ogihara","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2023.109756_bib166","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ntt.2018.01.005","article-title":"S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice","volume":"71","author":"Ornoy","year":"2019","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib167","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","article-title":"Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics","volume":"57","author":"Ortiz","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib168","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1523\/JNEUROSCI.1359-10.2010","article-title":"Manipulation of adenosine kinase affects sleep regulation in mice","volume":"30","author":"Palchykova","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib169","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000322288","article-title":"Differential effects of ziprasidone and haloperidol on immobilization-stress-induced CRF mRNA expression in the hypothalamic paraventricular nucleus of rats","volume":"63","author":"Park","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","article-title":"The role of electroconvulsive therapy (ECT) in bipolar disorder: effectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features","volume":"15","author":"Perugi","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib171","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/joim.13056","article-title":"Psychiatric and neurocognitive consequences of endogenous hypercortisolism","volume":"288","author":"Piasecka","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neuropharm.2023.109756_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031555","article-title":"Genetic and epigenetic markers of lithium response","volume":"23","author":"Pisanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib173","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/07853899908998788","article-title":"Adenosine in sleep and wakefulness","volume":"31","author":"Porkka-Heiskanen","year":"1999","journal-title":"Ann. Med."},{"key":"10.1016\/j.neuropharm.2023.109756_bib174","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0306-4522(00)00220-7","article-title":"Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study","volume":"99","author":"Porkka-Heiskanen","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109756_bib175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/7854_2020_172","article-title":"The kindling\/sensitization model and early life stress","volume":"48","author":"Post","year":"2021","journal-title":"Curr. Top Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib176","first-page":"153","article-title":"Rational polypharmacy in the bipolar affective disorders","volume":"11","author":"Post","year":"1996","journal-title":"Epilepsy Res. Suppl."},{"key":"10.1016\/j.neuropharm.2023.109756_bib177","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2023.109756_bib178","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/hmg\/9.14.2159","article-title":"Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency","volume":"9","author":"Race","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2023.109756_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136620","article-title":"The possible role of nitric oxide signaling and NMDA receptors in allopurinol effect on maximal electroshock- and pentylenetetrazol-induced seizures in mice","volume":"778","author":"Rahimi","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109756_bib180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YCT.0b013e31827e5672","article-title":"Does electroconvulsive therapy cause epilepsy?","volume":"29","author":"Ray","year":"2013","journal-title":"J. ECT"},{"key":"10.1016\/j.neuropharm.2023.109756_bib181","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/0006-2952(83)90222-8","article-title":"On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency","volume":"32","author":"Reiter","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib182","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31887\/DCNS.2002.4.1\/jreul","article-title":"On the role of corticotropin-releasing hormone receptors in anxiety and depression","volume":"4","author":"Reul","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib183","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-022-00651-8","article-title":"The metabolic basis of epilepsy","volume":"18","author":"Rho","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2023.109756_bib184","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JAD-2010-1379","article-title":"Caffeine and adenosine","volume":"20","author":"Ribeiro","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2023.109756_bib185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0920-1211(91)90070-V","article-title":"Plasma uric acid in patients receiving anticonvulsant monotherapy","volume":"8","author":"Ring","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib186","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3945\/an.115.010843","article-title":"The pediatric methionine requirement should incorporate remethylation potential and transmethylation demands","volume":"7","author":"Robinson","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.552567","article-title":"The modulatory role of cortisol in the regulation of sexual behavior in young males","volume":"14","author":"Rodriguez-Nieto","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020908","article-title":"Psychotropic drug effects on steroid stress hormone release and possible mechanisms involved","volume":"23","author":"Romanova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib189","article-title":"Oral administration of S-adenosylmethionine (SAMe) and lactobacillus plantarum HEAL9 improves the mild-to-moderate symptoms of depression: a randomized, double-blind, placebo-controlled study","volume":"22","author":"Saccarello","year":"2020","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11302-011-9242-y","article-title":"Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling","volume":"7","author":"Sadek","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2023.109756_bib191","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yebeh.2018.06.041","article-title":"Deep brain stimulation for epilepsy","volume":"88S","author":"Salanova","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109756_bib192","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.focus.20160017","article-title":"Mood disorders in epilepsy","volume":"14","author":"Salpekar","year":"2016","journal-title":"Focus"},{"key":"10.1016\/j.neuropharm.2023.109756_bib193","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eplepsyres.2016.09.014","article-title":"The impact of sleep loss on the facilitation of seizures: a prospective case-crossover study","volume":"127","author":"Samsonsen","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib194","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/epi.14674","article-title":"Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice","volume":"60","author":"Sandau","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MED.0000000000000633","article-title":"Psychological complications of Cushing's syndrome","volume":"28","author":"Santos","year":"2021","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.neuropharm.2023.109756_bib196","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/bdi.13013","article-title":"Ketogenic diet in bipolar disorder","volume":"22","author":"Saraga","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib197","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11064-005-2682-4","article-title":"GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions","volume":"30","author":"Saransaari","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib198","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0896-6273(92)90244-8","article-title":"Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus","volume":"9","author":"Scanziani","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109756_bib199","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0957154X10396807","article-title":"'On periodical depressions and their pathogenesis' by Carl Lange (1886)","volume":"22","author":"Schioldann","year":"2011","journal-title":"Hist. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00115-011-3340-5","article-title":"[Psychiatric aspects of epileptic disorders]","volume":"83","author":"Schmitz","year":"2012","journal-title":"Nervenarzt"},{"key":"10.1016\/j.neuropharm.2023.109756_bib201","article-title":"The role of ketogenic metabolic therapy on the brain in serious mental illness: a review","volume":"7","author":"Sethi","year":"2022","journal-title":"J. Psychiatr. Brain Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/YCT.0b013e31824d1dc0","article-title":"Maintenance ECT as a therapeutic approach to medication-refractory epilepsy in an adult with mental retardation: case report and review of literature","volume":"28","author":"Shah","year":"2012","journal-title":"J. ECT"},{"key":"10.1016\/j.neuropharm.2023.109756_bib203","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0278-5846(01)00154-3","article-title":"The mechanism of lithium action: state of the art, ten years later","volume":"25","author":"Shaldubina","year":"2001","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib204","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00702-009-0298-6","article-title":"Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?","volume":"116","author":"Shaltiel","year":"2009","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2023.109756_bib205","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI62378","article-title":"Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia","volume":"122","author":"Shen","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109756_bib206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-8993(94)91141-X","article-title":"The alpha 2-agonist clonidine suppresses seizures, whereas the alpha 2-antagonist idazoxan promotes seizures--a microinfusion study in amygdala-kindled kittens","volume":"648","author":"Shouse","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib207","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00004714-198806000-00009","article-title":"Lithium in the treatment of bipolar disorders associated with epilepsy: an open study","volume":"8","author":"Shukla","year":"1988","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib208","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00005053-199702000-00007","article-title":"Mechanism of disinhibition after brain lesions","volume":"185","author":"Starkstein","year":"1997","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neuropharm.2023.109756_bib209","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58741","article-title":"Reduced purine biosynthesis in humans after their divergence from Neandertals","volume":"10","author":"Stepanova","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2023.109756_bib210","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1038\/s41598-021-87955-9","article-title":"Induced pluripotent stem cells from subjects with Lesch-Nyhan disease","volume":"11","author":"Sutcliffe","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109756_bib211","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2023.109756_bib212","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1038\/s41598-022-10415-5","article-title":"Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling data","volume":"12","author":"Thistlethwaite","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109756_bib213","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0166-2236(93)90160-N","article-title":"Presynaptic inhibition in the hippocampus","volume":"16","author":"Thompson","year":"1993","journal-title":"TINS (Trends Neurosci.)"},{"key":"10.1016\/j.neuropharm.2023.109756_bib214","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.expneurol.2016.01.001","article-title":"Uric acid is released in the brain during seizure activity and increases severity of seizures in a mouse model for acute limbic seizures","volume":"277","author":"Thyrion","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1982.tb01626.x","article-title":"Effects of TSH on cAMP levels and thyroid hormone release in human thyroid 'autonomous' nodules: relationship with iodothyronine and iodine content in thyroglobulin","volume":"17","author":"Toccafondi","year":"1982","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib216","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.arcmed.2006.10.010","article-title":"Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial","volume":"38","author":"Togha","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib217","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1021\/acs.jmedchem.6b00689","article-title":"South (S)- and north (N)-Methanocarba-7-Deazaadenosine analogues as inhibitors of human adenosine kinase","volume":"59","author":"Toti","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2023.109756_bib218","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib219","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1523\/JNEUROSCI.0589-04.2004","article-title":"Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures","volume":"24","author":"Tsankova","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib220","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/jn\/132.9.2737","article-title":"Acute valproate administration impairs methionine metabolism in rats","volume":"132","author":"Ubeda","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib221","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bdi.12503","article-title":"Lithium ameliorates sleep deprivation-induced mania-like behavior, hypothalamic-pituitary-adrenal (HPA) axis alterations, oxidative stress and elevations of cytokine concentrations in the brain and serum of mice","volume":"19","author":"Valvassori","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib222","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0922-4106(91)90111-T","article-title":"Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses","volume":"206","author":"Van Calker","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib223","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/brain\/aww071","article-title":"Cortisol fluctuations relate to interictal epileptiform discharges in stress sensitive epilepsy","volume":"139","author":"van Campen","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2023.109756_bib224","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yebeh.2015.04.071","article-title":"Seizure occurrence and the circadian rhythm of cortisol: a systematic review","volume":"47","author":"van Campen","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109756_bib225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2009.10.009","article-title":"Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine","volume":"19","author":"van Delft","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109756_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104658","article-title":"Higher cortisol levels may proceed a manic episode and are related to disease severity in patients with bipolar disorder","volume":"119","author":"van den Berg","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2023.109756_bib227","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41582-022-00727-5","article-title":"Astrocytes in the initiation and progression of epilepsy","volume":"18","author":"Vezzani","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib228","first-page":"165","article-title":"Rare conduction abnormality in a four-year-old child with carbamazepine acute poisoning","volume":"14","author":"Vivisenco","year":"2019","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/j.neuropharm.2023.109756_bib229","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(94)00734-O","article-title":"The effects of adenosine A3 receptor stimulation on seizures in mice","volume":"275","author":"Von Lubitz","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-018-9930-2","article-title":"Serum uric acid is highly associated with epilepsy secondary to cerebral infarction","volume":"35","author":"Wang","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2023.109756_bib231","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0000000000000076","article-title":"Caffeine-induced psychiatric manifestations: a review","volume":"30","author":"Wang","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib232","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.159.4.576","article-title":"Sleep-loss as a possible mediator of diverse causes of mania","volume":"159","author":"Wehr","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib233","first-page":"201","article-title":"Sleep reduction as a final common pathway in the genesis of mania","volume":"144","author":"Wehr","year":"1987","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109756_bib234","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41398-019-0681-5","article-title":"On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D(2\/3) receptor agonist radioligand study","volume":"10","author":"Weidenauer","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082834","article-title":"Prenatal S-adenosine methionine (SAMe) induces changes in gene expression in the brain of newborn mice that are prevented by Co-administration of valproic acid (VPA)","volume":"21","author":"Weinstein-Fudim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib236","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215278","article-title":"Gender related changes in gene expression induced by valproic acid in A mouse model of autism and the correction by S-adenosyl methionine. Does it explain the gender differences in autistic like behavior?","volume":"20","author":"Weinstein-Fudim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib237","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2023.109756_bib238","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresbull.2018.11.008","article-title":"The role of adenosine in epilepsy","volume":"151","author":"Weltha","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"Suppl. 8","key":"10.1016\/j.neuropharm.2023.109756_bib239","first-page":"5","article-title":"Mechanism of action of newer anticonvulsants","volume":"64","author":"White","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2023.109756_bib240","first-page":"S177","article-title":"Overlapping phenomena of bipolar disorder and epilepsy--a common pharmacological pathway","volume":"27","author":"Wiglusz","year":"2015","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.neuropharm.2023.109756_bib241","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1172\/JCI65636","article-title":"Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis","volume":"123","author":"Williams-Karnesky","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109756_bib242","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00406-013-0479-z","article-title":"Neuropathological changes in the substantia nigra in schizophrenia but not depression","volume":"264","author":"Williams","year":"2014","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109756_bib243","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.163.5.679","article-title":"Mania following sleep deprivation","volume":"163","author":"Wright","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109756_bib244","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1752-0509-5-72","article-title":"Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition","volume":"5","author":"Xiao","year":"2011","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib245","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9241835","article-title":"Natural adrenocorticotropic hormone (ACTH) relieves acute inflammation in gout patients by changing the function of macrophages","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Healthc. Eng."},{"key":"10.1016\/j.neuropharm.2023.109756_bib246","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-4632.2007.03269.x","article-title":"Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient","volume":"46","author":"Yang","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib247","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3988\/jcn.2019.15.4.496","article-title":"Elevated serum uric acid in benign convulsions with mild gastroenteritis in children","volume":"15","author":"Yoo","year":"2019","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib248","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1139\/y82-041","article-title":"The effect of diazepam on adenosine uptake and adenosine-stimulated adenylate cyclase in Guinea-pig brain","volume":"60","author":"York","year":"1982","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109756_bib249","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1528-1157.1994.tb02919.x","article-title":"Allopurinol as add-on therapy in refractory epilepsy: a double-blind placebo-controlled randomized study","volume":"35","author":"Zagnoni","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109756_bib250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.seizure.2015.12.015","article-title":"Electroconvulsive therapy for refractory status epilepticus: a systematic review","volume":"35","author":"Zeiler","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109756_bib251","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0736-5748(95)00054-2","article-title":"Developmental changes in purine nucleotide metabolism in cultured rat astroglia","volume":"13","author":"Zoref-Shani","year":"1995","journal-title":"Int. J. Dev. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:26:42Z","timestamp":1758439602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823003465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":254,"alternative-id":["S0028390823003465"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109756","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109756"}}